The Catalonia Suicide Risk Code Epidemiology Study: an Epidemiological Study of Suicide Attempts in Catalonia, Spain
NCT04235127 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 186000
Last updated 2020-01-28
Summary
Suicide attempts (SA) constitute a major public health issue worldwide. Research suggests that 2.7% of adult people ever attempt suicide; among children and adolescents this is estimated to be 6.0%. SA are related to subsequent suicide which represents an annual loss of 34.6 million years of life worldwide. Suicide attempts are also related to persistent physical and mental health issues, psychiatric hospitalizations, impaired academic performance, unemployment, partner abuse victimization and perpetration, having children removed by social services, loneliness, relationship difficulties, impaired social functioning and low life satisfaction. Despite this considerable societal impact, there is a lack of epidemiological research focussing on providing suicide attempt surveillance in the population, to inform public health action aimed at reducing risk for suicide attempts in the population, and to provide data-driven support for suicide risk assessment across healthcare settings. To address this shortcoming, the investigators designed the Catalonia Suicide Risk Code Epidemiology study. Using centralized Electronic Healthcare Record data from the entire public healthcare system of Catalonia, Spain, the CSRC-Epi study aims to estimate reliable suicide incidence rates, identify suicide attempt risk factors, and develop validated suicide attempt risk prediction tools.
Conditions
- Suicide, Attempted
- Suicide
- Suicide and Self-harm
Interventions
- OTHER
-
sociodemographic variables, somatic conditions, mental disorders, treatment and drug use
* sociodemographic variables * history of self-injurious behaviours; all types of somatic conditions; neurodevelopmental, mental, behavioural, personality and substance use disorders; all types of medical procedures performed; and number and type of healthcare contacts. * prescriptions for psychopharmacological products * the Suicidal Scale of the Mini-International Neuropsychiatric Interview, the type and lethality of the attempt that warranted evaluation, presence and type of mental disorder, hopelessness, impulsivity, aggressiveness, altered state of conscience, use or dependence of alcohol, use or dependence of illicit drugs, serious somatic disease (including chronic diseases, chronic pain, and disabilities), living status, presence of family or social support, social problems, stressful life events, access to lethal means, and family history of suicide
Sponsors & Collaborators
-
Catalan Agency for Health Information, Assessment and Quality
collaborator OTHER_GOV -
National Centre for Suicide Research and Prevention, Norway
collaborator UNKNOWN -
Harvard Medical School (HMS and HSDM)
collaborator OTHER -
Hospital del Mar Research Institute (IMIM)
lead OTHER
Eligibility
- Min Age
- 10 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-06-30
- Primary Completion
- 2019-12-31
More Related Trials
-
Drivers of Suicide Mobile App Study
NCT05427734 ·Status: COMPLETED ·Phase: NA
-
Ibogaine in the Treatment of Alcoholism: an Open-label Escalating-dose Trial
NCT03380728 ·Status: COMPLETED ·Phase: PHASE2
-
Fluoxetine and Bupropion to Treat Patients With Depression and Alcoholism
NCT00449007 ·Status: TERMINATED ·Phase: PHASE4
-
Ketamine for Depression and Alcohol Dependence
NCT01551329 ·Status: COMPLETED ·Phase: PHASE1
-
Bristol Imperial MDMA in Alcoholism Study
NCT04158778 ·Status: UNKNOWN ·Phase: PHASE1
-
Bilateral Prefrontal Modulation in Alcoholism
NCT02091284 ·Status: COMPLETED ·Phase: NA
-
Injectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious Mental Illness (SMI)
NCT00453804 ·Status: COMPLETED ·Phase: PHASE4
-
A Randomized, Double-blind Placebo-Controlled Pharmacogenetic Study of Topiramate in European-American Heavy Drinkers
NCT02371889 ·Status: COMPLETED ·Phase: PHASE2
-
Virtual Reality Cognitive Training in Alcohol Use Disorder
NCT04505345 ·Status: UNKNOWN ·Phase: NA
-
Antabuse in Severe Alcoholism: an Open Controlled Study
NCT00431262 ·Status: UNKNOWN ·Phase: PHASE4
-
An Efficacy and Safety Study of Topiramate in the Treatment of Alcohol Dependence
NCT00210925 ·Status: COMPLETED ·Phase: PHASE2
-
Topiramate for Hospitalized Patients With Alcoholism: a 12-week Study
NCT01135602 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effects of Topiramate on Alcohol Use in Alcohol Dependent Subjects
NCT00329407 ·Status: COMPLETED ·Phase: PHASE4
-
Ketamine for Reduction of Alcoholic Relapse
NCT02649231 ·Status: COMPLETED ·Phase: PHASE2
-
Brief New Treatment for Suicide Attempts
NCT03300596 ·Status: COMPLETED ·Phase: NA
-
Defining the Clinical Role of Topiramate in the Treatment of Alcohol Dependence in Australia
NCT03479086 ·Status: UNKNOWN ·Phase: PHASE3
-
Attempted Suicide Short Intervention Program: a Randomized Controlled Trial
NCT03732300 ·Status: COMPLETED ·Phase: NA
-
Safety and Pharmacodynamic Study of GET 73 in Alcohol Dependent
NCT01842503 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Trial of the Rapid Antisuicidal Effects of Intranasal Ketamine in Comorbid Depression and Alcohol Abuse
NCT03539887 ·Status: COMPLETED ·Phase: PHASE3
-
Dexmedetomidine as Adjunctive Therapy for Alcohol Withdrawal
NCT00936377 ·Status: COMPLETED ·Phase: NA
-
Study of 18 mg Selincro® As-needed Use, in the Treatment of Patients With Alcohol Dependence in Primary Care
NCT02195817 ·Status: TERMINATED ·Phase: PHASE4
-
Efficacity of rTMS in Alcohol Dependance
NCT01569399 ·Status: COMPLETED ·Phase: NA
-
Developing Functional Connectivity-Guided TMS for Alcohol Use Disorder
NCT06415721 ·Status: RECRUITING ·Phase: NA
-
Prevalence of Chronic Inebriates to the Emergency Department and Suitability for Sobering House Services
NCT01783223 ·Status: COMPLETED
-
Combining Medications for the Treatment of Alcohol Dependence: An Inpatient Preliminary Study
NCT00769158 ·Status: COMPLETED ·Phase: PHASE1